Stocks
MAPLEBEAR INC. CMNMAP
NASDAQHealthcareBiotechnology
A specialty pharmaceutical company focused on developing and commercializing therapies for rare and serious diseases, with a pipeline centered on enzyme replacement treatments. Its lead product targets a lysosomal storage disorder, and investors track it for its clinical milestones and commercial execution in a niche market.
52W Range: $0.15-$0.15
Congressional Interest in MAPLEBEAR INC. CMN (MAP)
1 member of Congress has disclosed 1 trade in MAPLEBEAR INC. CMN (MAP), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading MAP?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-09-10 | Rohit Khanna | sell | $1K-$15K |